Pharma Journalist -

Pfizer Inc. announced detailed overall survival (OS) data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus…
Read More...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an…
Read More...

Amneal Pharmaceuticals announced that it has received FDA approval for a generic version of BiCNU (carmustine) for injection, 100 mg. The Company is planning to commercialize its…
Read More...

apceth Biopharma GmbH announced positive results for apceth-201 in mouse models for acute graft-versus-host disease (aGvHD). The data was highlighted in a poster presentation at the…
Read More...

AbbVie and Morphic Therapeutic announced that the companies have entered into a research and development collaboration designed to advance a number of Morphic's oral integrin…
Read More...

Daiichi Sankyo Company announced that the first patient has been dosed in a first-in-human phase 1 study assessing the safety and tolerability of DS-1205, a highly selective…
Read More...

AstraZeneca and Merck announced that they were granted orphan drug designation (ODD) by the US Food and Drug Administration (FDA) for Lynparza (olaparib) for the treatment of pancreatic…
Read More...

Endocyte announced that it has entered into an agreement and plan of merger with Novartis AG pursuant to which Novartis will acquire Endocyte for $24 per share, or a total equity value…
Read More...

Iovance Biotherapeutics and MaSTherCell announced that the two companies have entered into a new three-year Manufacturing Services Agreement. MaSTherCell will manufacture TIL for…
Read More...

Hovione announces plan to increase production capacity in oral dosage forms in Portugal, to strengthen the integrated offering. New commercial scale equipment for blending, tableting…
Read More...